Overview
Oladapo Yeku is a Hematologist Oncology specialist and an Oncologist in Boston, Massachusetts. Dr. Yeku is highly rated in 7 conditions, according to our data. His top areas of expertise are Ovarian Cancer, Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, and Endometrial Cancer. Dr. Yeku is currently accepting new patients.
His clinical research consists of co-authoring 56 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Dana-Farber Cancer Institute, Inc.
David Reardon is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Reardon is highly rated in 22 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Caron Jacobson is an Oncologist and a Hematologist in Boston, Massachusetts. Dr. Jacobson is highly rated in 25 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jacobson is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Daniel Deangelo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Deangelo is highly rated in 35 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Deangelo is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Ovarian CancerDr. Yeku isDistinguished. Learn about Ovarian Cancer.
- Ovarian CarcinosarcomaDr. Yeku isDistinguished. Learn about Ovarian Carcinosarcoma.
- Testicular Yolk Sac TumorDr. Yeku isDistinguished. Learn about Testicular Yolk Sac Tumor.
- Advanced
- Endometrial CancerDr. Yeku isAdvanced. Learn about Endometrial Cancer.
- Malignant Mixed Mullerian Tumor
- Sertoli-Leydig Cell TumorDr. Yeku isAdvanced. Learn about Sertoli-Leydig Cell Tumor.
- Virilizing Ovarian TumorDr. Yeku isAdvanced. Learn about Virilizing Ovarian Tumor.
- Experienced
- Cervical CancerDr. Yeku isExperienced. Learn about Cervical Cancer.
- Desmoplastic Small Round Cell TumorDr. Yeku isExperienced. Learn about Desmoplastic Small Round Cell Tumor.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Embryonal Tumor with Multilayered Rosettes
- Endometrial Stromal SarcomaDr. Yeku isExperienced. Learn about Endometrial Stromal Sarcoma.
- Large-Cell Immunoblastic LymphomaDr. Yeku isExperienced. Learn about Large-Cell Immunoblastic Lymphoma.